Dmitri Wiederschain
Dmitri Wiederschain publishes mostly in Molecular Biology, Oncology and Immunology, on topics such as Cancer-related Molecular Pathways, CAR-T cell therapy research and Monoclonal and Polyclonal Antibodies Research.
- World rank
- #119,217 of 7,710,434 ranked researchers
- Rank in France
- #9,102 of 324,115
- Works
- 180
- Citations
- 7.1k
- Citations per work
- 39.6
What does Dmitri Wiederschain research?
Dmitri Wiederschain's work is mostly in Biochemistry, Genetics and Molecular Biology (34%), Medicine (31%), Immunology and Microbiology (12%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences8245.8%
- Health Sciences5630.9%
- Medicine5630.9%
- Everything else4223.3%
- 1Molecular Biology24% of their works
- 2Oncology19% of their works
- 3Immunology12% of their works
- 4Cancer Research10% of their works
- 5Radiology, Nuclear Medicine and Imaging6% of their works
- 6Hematology5% of their works
Research topics
Which keywords describe Dmitri Wiederschain's research?
The keywords of their largest research topics: Cancer Immunotherapy, Immunotherapy, Tumor Regression, CAR T Cells, Cell Cycle, Chimeric Antigen Receptor, Fc Receptors and p53.
- Bacterial Therapy
- NK Cell Recognition
- Histone Modification
- DNA Methylation
- Matrix Metalloproteinases
- Therapeutic Antibodies
- Chimeric Antigen Receptor
- CAR T Cells
- Immunotherapy
- Cancer Immunotherapy
- Tumor Regression
- Cell Cycle
- Fc Receptors
- p53
- Tissue Inhibitors of Metalloproteinases
- Dendritic Cells
- Immunity
- Natural Killer Cells
- Tumor Targeting
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 19 words, with their numbers
- Cancer Immunotherapy232 topics
- Immunotherapy222 topics
- Tumor Regression222 topics
- CAR T Cells141 topic
- Cell Cycle141 topic
- Chimeric Antigen Receptor141 topic
- Fc Receptors141 topic
- Therapeutic Antibodies141 topic
- p53141 topic
- Matrix Metalloproteinases101 topic
- Tissue Inhibitors of Metalloproteinases101 topic
- DNA Methylation91 topic
- Dendritic Cells91 topic
- Histone Modification91 topic
- Immunity91 topic
- NK Cell Recognition91 topic
- Natural Killer Cells91 topic
- Bacterial Therapy81 topic
- Tumor Targeting81 topic
Where does Dmitri Wiederschain work?
Dmitri Wiederschain's main affiliation in the publication record is Sanofi (France), France.
How many publications and citations does Dmitri Wiederschain have?
OpenAlex counts 180 works and 7,135 citations for Dmitri Wiederschain, an h-index of 38, ranking #119,217 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Dmitri Wiederschain. Posts are plain text and can be reported.